FDA Rips Research Co. Over Unapproved Electromagnet Trials

Law360, New York (February 25, 2014, 6:32 PM EST) -- The U.S. Food and Drug Administration chastised an electromagnetic treatment center over "objectionable" practices including carrying out at least three clinical trials for a nonapproved electromagnetic device without obtaining the approval of a review panel overseen by the agency, according to a warning letter released Monday. 

Nevada-based Advanced Magnetic Research Institute International LLC was hit with a warning letter by the FDA for carrying out three clinical trials for its so-called magnetic molecular energizer device without obtaining the approval of an institutional review board. The device...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.